Founded in 1995, the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS®) is a collaborative community of leaders from the United States and Canada. The committee is dedicated to advancing the treatment and research related to Multiple Sclerosis (MS) and other demyelinating diseases.
Key Objectives of ACTRIMS:
Knowledge Dissemination: ACTRIMS serves as a platform for the dissemination of knowledge related to the treatment and research of MS and demyelinating diseases.
Education: The committee is actively involved in educational initiatives, providing resources and information to professionals and stakeholders in the field.
Collaboration Among Disciplines: ACTRIMS fosters collaboration among professionals from various disciplines involved in the study and treatment of MS, promoting a multidisciplinary approach.
The focus on treatment and research underscores the commitment of ACTRIMS to making advancements in understanding and managing multiple sclerosis. The collaborative efforts aim to improve patient outcomes, enhance education, and contribute to the broader field of neurology.
